Cranberries and their bioactive constituents in human health

Advances in Nutrition

Volumn 4, Issue 6, 2013, Pages 618-632

  Blumberg, Jeffrey B ^a   Camesano, Terri A ^b   Cassidy, Aedin ^c   Kris Etherton, Penny ^d   Howell, Amy ^e   Manach, Claudine ^f   Ostertag, Luisa M ^c   Sies, Helmut ^g   Skulas Ray, Ann ^d   Vita, Joseph A ^h  

^a TUFTS UNIVERSITY   (United States)

^b Worcester Polytechnic Institute   (United States)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f INRA and University of Auvergne   (France)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PHENOL DERIVATIVE; PLANT EXTRACT; PROANTHOCYANIDIN;

CARDIOVASCULAR DISEASE; CHEMISTRY; CRANBERRY; DIET; FRUIT; HUMAN; PHYTOTHERAPY; REVIEW; URINARY TRACT INFECTION;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET; FRUIT; HUMANS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; PROANTHOCYANIDINS; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 84895162150     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.113.004473     Document Type: Review

References (156)

1. USDA; U.S. Department of Health and Human Services. Dietary guidelines for Americans, 2010. 7th ed.Washington: U.S. Government Printing Office; 2010.
2. Paredes-López O, Cervantes-Ceja ML, Vigna-Pérez M, Hernández-Pérez T. Berries: improving human health and healthy aging, and promoting quality life-a review. Plant Foods Hum Nutr. 2010;65: 299-308.
3. Côté J, Caillet S, Doyon G, Sylvain JF, Lacroix M. Bioactive compounds in cranberries and their biological properties. Crit Rev Food Sci Nutr. 2010;50:666-79.
4. Basu A, Lyons TJ. Stawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J Agric Food Chem. 2012;60: 5687-92.
5. Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY, Lee CC, Chen SC. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and metaanalysis of randomized controlled trials. Arch Intern Med. 2012; 172:988-96.
6. Kaspar KL, Khoo C. Cranberry polyphenols in the promotion of urinary tract, cardiovascular and emerging health areas. In: Skinner M, Hunter D, editors. Bioactives in fruit: health benefits and functional foods. New York: Wiley Blackwell; 2013. p. 273-92.
7. McKay DL, Blumberg JB. Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev. 2007;65:490-502.
8. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal. 2013;18:1818-92.
9. Kim MJ, Ohn J, Kim JH, Kwak HK. Effects of freeze-dried cranberry powder on serum lipids and inflammatory markers in lipopolysaccharide treated rats fed an atherogenic diet. Nutr Res Pract. 2011;5: 404-11.
10. Yung LM, Wong WT, Tian XY, Leung FP, Yung LH, Chen ZY, Yao X, Lau CW, Huang Y. Inhibition of renin-angiotensin system reverses endothelial dysfunction and oxidative stress in estrogen deficient rats. PLoS ONE. 2011;6:e17437.
11. Xiao SD, Shi T. Is cranberry juice effective in the treatment and prevention of Helicobacter pylori infection of mice? Chin J Dig Dis. 2003; 4:136-9.
12. Zhu Y, Xia M, Yang Y, Liu F, Li Z, Hao Y, Mi M, Jin T, Ling W. Purified anthocyanin supplementation improves endothelial function via NO-cGMP activation in hypercholesterolemic individuals. Clin Chem. 2011;57:1524-33.
13. Lee IT, Chan YC, Lin CW, Lee WJ, Sheu WH. Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes. Diabet Med. 2008;25:1473-7.
14. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr. 2006;96: 357-64.
15. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, Titas M, Kluge MA, Wang N, Palmisano J, Milbury PE, et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr. 2011;93:934-40.
16. Flammer AJ, Martin EA, Gossl M, Widmer RJ, Lennon RJ, Sexton JA, Loeffler D, Khosla S, Lerman LO, Lerman A. Polyphenol-rich cranberry juice has a neutral effect on endothelial function but decreases the fraction of osteocalcin-expressing endothelial progenitor cells. Eur J Nutr. 2013;52:289-96.
17. Wilson T, Luebke JL, Morcomb EF, Carrell EJ, Leveranz MC, Kobs L, Schmidt TP, Limburg PJ, Vorsa N, Singh AP. Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes. J Food Sci. 2010;75:H218-23.
18. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism. 2005;54:856-61.
19. Duthie SJ, Jenkinson AM, Crozier A, Mullen W, Pirie L, Kyle J, Yap LS, Christen P, Duthie GG. The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur J Nutr. 2006;45:113-22.
20. Vinson JA, Bose P, Proch J, Kharrat HA, Samman N. Cranberries and cranberry products: powerful in vitro, ex vivo, and in vivo sources of antioxidants. J Agric Food Chem. 2008;56:5884-91.
21. Gotteland M, Andrews M, Toledo M, Muñoz L, Caceres P, Anziani A, Wittig E, Speisky H, Salazar G. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition. 2008;24:421-6.
22. Shmuely H, Yahav J, Samra Z, Chodick G, Koren R, Niv Y, Ofek I. Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antiobiotics and a proton pump inhibitor. Mol Nutr Food Res. 2007;51:746-51.
23. Weiss EI, Kozlovsky A, Steinberg D, Lev-Dor R, Bar Ness Greenstein R, Feldman M, Sharon N, Ofek I. A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett. 2004;232:89-92.
24. Basu A, Betts NM, Ortiz J, Simmons B, Wu M, Lyons TJ. Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res. 2011;31: 190-6.
25. Vasileiou I, Katsargyris A, Theocharis S, Giaginis C. Current clinical status on the preventive effects of cranberry consumption against urinary tract infections. Nutr Res. 2013;33:595-607.
26. Pappas E, Schaich KM. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit Rev Food Sci Nutr. 2009;49:741-81.
27. White BL, Howard LR, Prior RL. Impact of different stages of juice processing on the anthocyanin, flavonol, and procyanidin contents of cranberries. J Agric Food Chem. 2011;59:4692-8.
28. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Gebhardt S, Prior RL. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr. 2004; 134:613-7.
29. Foo LY, Lu YR, Howell AB, Vorsa N. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry. 2000;54:173-81.
30. Feliciano RP, Krueger CG, Shanmuganayagam D, Vestling MM, Reed JD. Deconvolution of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry isotope patterns to determine ratios of A-type to B-type interflavan bonds in cranberry proanthocyanidins. Food Chem. 2012;135:1485-93.
31. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005;66:2281-91.
32. Jungfer E, Zimmermann BF, Ruttkat A, Galensa R. Comparing procyanidins in selected vaccinium species by UHPLC-MS(2) with regard to authenticity and health effects. J Agric Food Chem. 2012;60:9688-96.
33. USDA database for proanthocyanidin content of selected foods [database on the Internet]. Beltsville (MD): Nutrient Data Laboratory, Agricultural Research Service, USDA (in collaboration with The Arkansas Children's Nutrition Center; ARS; USDA; Mars, Inc.; and Ocean Spray Cranberries, Inc.); 2004 [cited 2013 May 28]. Available from: http://www.ars.usda.gov/Services/docs.htm?docid=5843.
34. Grace MH, Massey AR, Mbeunkui F, Yousef GG, Lila MA. Comparison of health-relevant flavonoids in commonly consumed cranberry products. J Food Sci. 2012;77:H176-83.
35. Reed JD, Krueger CG, Vestling MM. MALDI-TOF mass spectrometry of oligomeric food polyphenols. Phytochemistry. 2005;66:2248-63.
36. Saura-Calixto F. Concept and health-related properties of nonextractable polyphenols: the missing dietary polyphenols. J Agric Food Chem. 2012;60:11195-200.
37. Saura-Calixto F, Serrano J, Goñi I. Intake and bioaccessibility of total polyphenols in a whole diet. Food Chem. 2007;101:492-501.
38. Pérez-Jiménez J, Fezeu L, Touvier M, Arnault N, Manach C, Hercberg S, Galan P, Scalbert A. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011;93:1220-8.
39. Tarascou I,Mazauric JP, Meudec E, Souquet JM, Cunningham D, Nojeim S, Cheynier V, Fulcrand H. Characterisation of genuine and derived cranberry proanthocyanidins by LC-ESI-MS. Food Chem. 2011;128:802-10.
40. Wu X, Prior RL. Systematic identification and characterization of anthocyanins by HPLC-ESI-MS/MS in common foods in the United States: fruits and berries. J Agric Food Chem. 2005;53:2589-99.
41. Côté J, Caillet S, Doyon G, Sylvain JF, Lacroix M. Analyzing cranberry bioactive compounds. Crit Rev Food Sci Nutr. 2010;50:872-88.
42. Vvedenskaya IO, Vorsa N. Flavonoid composition over fruit development and maturation in American cranberry, Vaccinium macrocarpon Ait. Plant Sci. 2004;167:1043-54.
43. Celik H, Ozgen M, Serce S, Kaya C. Phytochemical accumulation and antioxidant capacity at four maturity stages of cranberry fruit. Sci Hortic (Amsterdam). 2008;117:345-8.
44. Brown PN, Murch SJ, Shipley P. Phytochemical Diversity of Cranberry (Vaccinium macrocarpon Aiton) Cultivars by Anthocyanin Determination and Metabolomic Profiling with Chemometric Analysis. J Agric Food Chem 2012;60:261-71.
45. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem. 2006;54:4069-75.
46. Crozier A, Del Rio D, Clifford MN. Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med. 2010;31:446-67.
47. Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. Human metabolism and excretion of the anthocyanin, cyanidin-3-glucoside: a 13C- tracer study. Am J Clin Nutr. 2013;97:995-1003.
48. Zuo Y, Wang C, Zhan J. Separation, characterization, and quantitation of benzoic and phenolic antioxidants in American cranberry fruit by GC-MS. J Agric Food Chem. 2002;50:3789-94.
49. Wang C, Zuo Y. Ultrasound-assisted hydrolysis and gas chromatography- mass spectrometric determination of phenolic compounds in cranberry products. Food Chem. 2011;128:562-8.
50. Zhang K, Zuo Y. GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juice. J Agric Food Chem. 2004;52:222-7.
51. Kondo M, MacKinnon SL, Craft CC, Matchett MD, Hurta RA, Neto CC. Ursolic acid and its esters: occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells. J Sci Food Agric. 2011;91:789-96.
52. Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti- and proinflammatory triterpenoid. Mol Nutr Food Res. 2008;52:26-42.
53. Turner A, Chen SN, Nikolic D, van Breemen R, Farnsworth NR, Pauli GF. Coumaroyl iridoids and a depside from cranberry (Vaccinium macrocarpon). J Nat Prod. 2007;70:253-8.
54. Mikulic-Petkovsek M, Slatnar A, Stampar F, Veberic R. HPLC-MSn identification and quantification of flavonol glycosides in 28 wild and cultivated berry species. Food Chem. 2012;135:2138-46.
55. Neveu V. Pérez-Jiménez J, Vos F, Crespy V, du Chaffaut L, Mennen L, Knox C, Eisner R, Cruz J, Wishart D, Scalbert A. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods [database on the Internet]. Paris: French National Institute for Agricultural Research (INRA); 2010 [cited 19 September 2013]. Available from: http://www.phenol-explorer.eu/.
56. Harnly JM, Doherty RF, Beecher GR, Holden JM, Haytowitz DB, Bhagwat S, Gebhardt S. Flavonoid content of US fruits, vegetables, and nuts. J Agric Food Chem. 2006;54:9966-77.
57. Häkkinen SH, Karenlampi SO, Heinonen IM, Mykkänen HM, Törrönen AR. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem. 1999;47:2274-9.
58. Keough GR. Massachusetts cranberries [Internet]. Concord (NH): New England Field Office, National Agricultural Statistics Service, USDA; 2013 [cited 19 September 2013]. Available from: http://www. nass.usda.gov/Statistics_by_State/New_England_includes/Publications/jancran.pdf.
59. Moco S, Bino RJ, Vorst O, Verhoeven HA, de Groot J, van Beek TA, Vervoort J, de Vos CH. A liquid chromatography-mass spectrometry- based metabolome database for tomato. Plant Physiol. 2006;141: 1205-18.
60. Iijima Y, Nakamura Y, Ogata Y, Tanaka K, Sakurai N, Suda K, Suzuki T, Suzuki H, Okazaki K, Kitayama M, et al. Metabolite annotations based on the integration of mass spectral information. Plant J. 2008; 54:949-62.
61. Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J Antimicrob Chemother. 2010;65:iii25-33.
62. Kontiokari T, Laitinen J, Järvi L, Pokka T, Sundqvist K, Uhari M. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr. 2003;77:600-4.
63. Kontiokari T, Nuutinen M, Uhari M. Dietary factors affecting susceptibility to urinary tract infection. Pediatr Nephrol. 2004;19:378-83.
64. Blatherwick NR, Long ML. Studies on urinary acidity: II. The increased acidity produced by eating prunes and cranberries. J Biol Chem. 1923;57:815-8.
65. Wollenweber E. Occurrence of flavonoid aglycones in medicinal plants. Prog Clin Biol Res. 1988;280:45-55.
66. Ohno T, Kita M, Yamaoka Y, Imamura S, Yananoto T, Mitsufuji S, Kodama T, Kashima K, Imanishi J. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter. 2003;8:207-15.
67. Howell AB, Vorsa N, Der Marderosian A, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med. 1998; 339:1085-6.
68. Howell AB, Botto H, Combescure C, Blanc-Potard AB, Gausa L, Matsumoto T, Tenke P, Sotto A, Lavigne JP. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis. 2010;10:94.
69. Tao Y, Pinzón-Arango PA, Howell AB, Camesano TA. Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. J Med Food. 2011;14:739-45.
70. Liu Y, Black MA, Caron L, Camesano TA. Role of cranberry juice on molecular- scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioeng. 2006;93:297-305.
71. Ahuja S, Kaack B, Roberts JA. Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of Pfimbriated Escherichia coli. J Urol. 1998;159:559-62.
72. Krueger CG, Reed JD, Feliciano RP, Howell AB. Quantifying and characterizing proanthocyanidins in cranberries in relation to urinary tract health. Anal Bioanal Chem. 2013;405:4385-95.
73. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsotz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994;271:751-4.
74. McMurdo ME, Bissett LY, Price RJ, Phillips G, Crombie IK. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing. 2005;34:256-61.
75. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321.
76. Moen DV. Observations on the effectiveness of cranberry juice in urinary infections. Wis Med J. 1962;61:282-3.
77. Walker EB, Barney DP, Mickelsen JN, Walton RJ, Mickelsen RA Jr. Cranberry concentrate: UTI prophylaxis. J Fam Pract. 1997;45:167-8.
78. Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011;52:23-30.
79. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9:1558-62.
80. Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarova-Yarovaya Y, Chen S, Gupta K. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial. Mayo Clin Proc. 2012;87:143-50.
81. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomized trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322:1571.
82. Foxman B, Geiger AM, Palin K, Gillespie B, Koopman JS. First-time urinary tract infection and sexual behavior. Epidemiology. 1995;6: 162-8.
83. Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L. Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol. 2009;43:369-72.
84. Foda MM, Middlebrook PF, Gatfield CT, Potvin G, Wells G, Schillinger JF. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol. 1995;2: 98-102.
85. Salo J, Uhari M, Helminen M, Korppi M, Nieminen T, Pokka T, Kontiokari T. Cranberry juice for the prevention of recurrences of urinary tract infections in children: a randomized placebo-controlled trail. Clin Infect Dis. 2012;54:340-6.
86. Afshar K, Stothers L, Scott H, MacNeily AE. Cranberry juice for prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol. 2012;188:1584-7.
87. Serrano J, Puupponen-Pimiä R, Dauer A, Aura A-M, Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res. 2009;53:S310-29.
88. Schmidt BM, Howell AB, McEniry B, Knight CT, Seigler D, Erdman JW Jr, Lila MA. Effective separation of potent antiproliferation and antiadhesion components from wild blueberry (Vaccinium angustifolium Ait.) fruits. J Agric Food Chem. 2004;52:6433-42.
89. Kimura H, Ogawa S, Akihiro T, Yokota K. Structural analysis of A-type or B-type highly polymeric proanthocyanidins by thiolytic degradation and the implication in their inhibitory effects on pancreatic lipase. J Chromatogr A. 2011;1218:7704-12.
90. Kylli P, Nohynek L, Puupponen-Pimiä R, Westerlund-Wikström B, Leppänen T, Welling J, Moilanen E, Heinonen M. Lingonberry (Vaccinium vitis-idaea) and European cranberry (Vaccinium microcarpon) proanthocyanidins: isolation, identification, and bioactivities. J Agric Food Chem. 2011;59:3373-84.
91. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med. 1991;324:1599.
92. Ofek I, Goldhar J, Sharon N. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. Adv Exp Med Biol. 1996;408:179-83.
93. Kalgaonkar S, Gross HB, Yokoyama W, Keen CL. Effects of a flavonolrich diet on select cardiovascular parameters in a Golden Syrian hamster model. J Med Food. 2010;13:108-15.
94. Yung LM, Tian XY, Wong WT, Leung FP, Yung LH, Chen ZY, Lau CW, Vanhoutte PM, Yao X, Huang Y. Chronic cranberry juice consumption restores cholesterol profiles and improves endothelial function in ovariectomized rats. Eur J Nutr. 2013;52:1145-55.
95. Reed J. Cranberry flavonoids, atherosclerosis, and cardiovascular health. Crit Rev Food Sci Nutr. 2002;42 Suppl:301-16.
96. Zhu Y, Ling W, Guo H, Song F, Ye Q, Zou T, Li D, Zhang Y, Li G, Xiao Y, et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial. Nutr Metab Cardiovasc Dis.
97. Qin Y, Xia M, Ma J, Hao Y, Liu J, Mou H, Cao L, Ling W. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr. 2009;90:485-92.
98. Chu YF, Liu RH. Cranberries inhibit LDL oxidation and induce LDL receptor expression in hepatocytes. Life Sci. 2005;77:1892-901.
99. Tall AR. CETP inhibitors to increase HDL cholesterol levels. N Engl J Med. 2007;356:1364-6.
100. Maher MA, Mataczynski H, Stefaniak HM, Wilson T. Cranberry juice induces nitric oxide-dependent vasodilation in vitro and its infusion transiently reduces blood pressure in anesthetized rats. J Med Food. 2000;3:141-7.
101. Apostolidis E, Kwon YI, Shetty K. Potential of cranberry-based herbal synergies for diabetes and hypertension management. Asia Pac J Clin Nutr. 2006;15:433-41.
102. Hassellund SS, Flaa A, Sandvik L, Kjeldsen SE, Rostrup M. Effects of anthocyanins on blood pressure and stress reactivity: a double-blind randomized placebo-controlled crossover study. J Hum Hypertens. 2012;26:396-404.
103. Khanal RC, Rogers TJ, Wilkes SE, Howard LR, Prior RL. Effects of dietary consumption of cranberry powder on metabolic parameters in growing rats fed high fructose diets. Food Funct. 2010;1:116-23.
104. Shabrova EV, Tarnopolsky O, Singh AP, Plutzky J, Vorsa N, Quadro L. Insights into the molecular mechanisms of the anti-atherogenic actions of flavonoids in normal and obese mice. PLoS ONE. 2011;6: e24634.
105. Chambers BK, Camire ME. Can cranberry supplementation benefit adults with type 2 diabetes? Diabetes Care. 2003;26:2695-6.
106. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-478.
107. Münzel T, Keaney JF Jr. Are ACE-inhibitors a "magic bullet" against oxidative stress? Circulation. 2001;104:1571-4.
108. Basu A, Rhone M, Lyons TJ. Berries: emerging impact on cardiovascular health. Nutr Rev. 2010;68:168-77.
109. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr. 2011;141 Suppl:989S-1009S.
110. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Low-calorie cranberry juice supplementation reduces plasma oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr. 2008;99:352-9.
111. Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and metaanalysis of women from primary prevention trials. Circulation. 2010;121:1069-77.
112. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a highmolecular- weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res. 2006;85: 235-9.
113. Huang Y, Nikolic D, Pendland S, Doyle BJ, Locklear TD, Mahady GB. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappa beta transcriptional response in vitro. Pharm Biol. 2009;47:18-25.
114. Bodet C, Chandad F, Grenier D. Cranberry components inhibit interleukin-6, interleukin-8, and prostaglandin E production by lipopolysaccharide- activated gingival fibroblasts. Eur J Oral Sci. 2007;115: 64-70.
115. Youdim KA, McDonald J, Kalt W, Joseph JA. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J Nutr Biochem. 2002;13:282-8.
116. Cimino F, Speciale A, Anwar S, Canali R, Ricciardi E, Virgili F, Trombetta D, Saija A. Anthocyanins protect human endothelial cells from mild hyperoxia damage through modulation of Nrf2 pathway. Genes Nutr. 2013;8:391-9.
117. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-60.
118. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S, et al. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753-67.
119. Tulio AZ Jr, Chang C, Edirisinghe I,White KD, Jablonski JE, Banaszewski K, Kangath A, Tadapaneni RK, Burton-Freeman B, Jackson LS. Berry fruits modulated endothelial cell migration and angiogenesis via phosphoinositide-3 kinase/protein kinase B pathway in vitro in endothelial cells. J Agric Food Chem. 2012;60:5803-12.
120. Paixão J, Dinis TC, Almeida LM. Malvidin-3-glucoside protects endothelial cells up-regulating endothelial NO synthase and inhibiting peroxynitrite- induced NF-kB activation. Chem Biol Interact. 2012;199: 192-200.
121. Milbury PE, Vita JA, Blumberg JB. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr. 2010; 140:1099-104.
122. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF Jr, Vita JA. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr. 2007;26:95-102.
123. Sies H. Polyphenols and health: update and perspectives. Arch Biochem Biophys. 2010;501:2-5.
124. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121: 505-11.
125. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875-81.
126. Mitchell GF. Arterial stiffness and wave reflection: biomarkers of cardiovascular risk. Artery Res. 2009;3:56-64.
127. Ruel G, Lapointe A, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Evidence that cranberry juice may improve augmentation index in overweight men. Nutr Res. 2013;33:41-9.
128. Deka A, Vita JA. Tea and cardiovascular disease. Pharmacol Res. 2011; 64:136-45.
129. Freedman JE, Parker C III, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 2001;103:2792-8.
130. Yang Y, Shi Z, Reheman A, Jin JW, Li C, Wang Y, Andrews MC, Chen P, Zhu G, Ling W, et al. Plant food delphinidin-3-glucoside significantly inhibits platelet activation and thrombosis: novel protective roles against cardiovascular diseases. PLoS ONE. 2012;7:e37323.
131. Wilson T, Meyers SL, Singh AP, Limburg PJ, Vorsa N. Favorable glycemic response of type 2 diabetics to low-calorie cranberry juice. J Food Sci. 2008;73:H241-5.
132. Wilson T, Singh AP, Vorsa N, Goettl CD, Kittleson KM, Roe CM, Kastello GM, Ragsdale FR. Human glycemic response and phenolic content of unsweetened cranberry juice. J Med Food. 2008;11:46-54.
133. Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S, Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci. 2012;17:355-60.
134. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Plasma matrix metalloproteinase (MMP)-9 levels are reduced following low-calorie cranberry juice supplementation in men. J Am Coll Nutr. 2009;28:694-701.
135. Duthie GG, Kyle JA, Jenkinson AM, Duthie SJ, Baxter GJ, Paterson JR. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem. 2005;53:2897-900.
136. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007; 85:895-909.
137. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95:454-64.
138. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation. 2013;127: 188-96.
139. Mursu J, Voutilainen S, Nurmi T, Tuomainen TP, Kurl S, Salonen JT. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2008;100:890-5.
140. Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary flavonoids and risk of stroke in women. Stroke. 2012;43:946-51.
141. Cassidy A, O'Reilly EJ, Kay C, Sampson L, Franz M, Forman J, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93:338-47.
142. Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane AM, Chowienczyk P, Jiang B, Cecelja M, Spector T, Macgregor A, et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr. 2012;96: 781-8.
143. Huxley RR, Neil HA. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2003;57:904-8.
144. Wang ZM, Nie ZL, Zhou B, Lian XQ, Zhao H, Gao W, Wang YS, Jia EZ, Wang LS, Yang ZJ. Flavonols intake and the risk of coronary heart disease: a meta-analysis of cohort studies. Atherosclerosis. 2012;222: 270-3.
145. Hollman PC, Geelen A, Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J Nutr. 2010;140:600-4.
146. Mursu J, Nurmi T, Tuomainen TP, Ruusunen A, Salonen JT, Voutilainen S. The intake of flavonoids and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2007;98:814-8.
147. Chun OK, Chung SJ, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in US adults. J Nutr. 2008;138:753-60.
148. Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, Hu FB, van Dam RM. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr. 2011;141:618-25.
149. Arts ICW, Jacobs DR Jr, Harnack LJ, Gross M, Folsom AR. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001;12:668-75.
150. Arts ICW, Hollman PCH, Feskens EJM, Bueno de Mesquita HB, Kromhout D. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:227-32.
151. Bhagwat SA, Haytowitz DB, Holden JM. USDA database for the flavonoid content of selected foods, release 3 [database on the Internet]. Beltsville (MD): Agricultural Research Service, USDA; 2011 [cited 2013 May 28]. Available from: http://www.ars.usda.gov/Services/docs.htm?docid=6231.
152. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26:1001-43.
153. Wang Y, Chung SJ, Song WO, Chun OK. Estimation of daily proanthocyanidin intake and major food sources in the US Diet. J Nutr. 2011;141:447-52.
154. Zamora-Ros R, Knaze V, Luján-Barroso L, Romieu I, Scalbert A, Slimani N, Hjartåker A, Engeset D, Skeie G, Overvad K, et al. Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2013;109:1498-507.
155. Knaze V, Zamora-Ros R, Luján-Barroso, Romieu I, Scalbert A, Slimani N, Riboli E, van Rossum CT, Bueno-de-Mesquita HB, Trichopoulou A, et al. Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr. 2012;108:1095-108.
156. Mullen W, Marks SC, Crozier A. Evaluation of phenolic compounds in commercial fruit juices and fruit drinks. J Agric Food Chem. 2007; 55:3148-57.